![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 44, 34280-34286, November 3, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Heritable Disorders Branch, NICHD, National Institutes of
Health, Bethesda, Maryland 20892
Deficiencies in glucose 6-phosphate (G6P)
transporter (G6PT), a 10-helical endoplasmic reticulum transmembrane
protein of 429 amino acids, cause glycogen storage disease type 1b. To
date, only three missense mutations in G6PT have been shown to abolish microsomal G6P transport activity. Here, we report the results of
structure-function studies on human G6PT and demonstrate that 15 missense mutations and a codon deletion (
Structural Requirements for the Stability and Microsomal
Transport Activity of the Human Glucose 6-Phosphate Transporter*
,
,
F93) mutation abolish microsomal G6P uptake activity and that two splicing mutations cause
exon skipping. While most missense mutants support the synthesis of
G6PT protein similar to that of the wild-type transporter, immunoblot
analysis shows that G20D,
F93, and I278N mutations, located in helix
1, 2, and 6, respectively, destabilize the G6PT. Further, we
demonstrate that G6PT mutants lacking an intact helix 10 are misfolded
and undergo degradation within cells. Moreover, amino acids 415-417 in
the cytoplasmic tail of the carboxyl-domain, extending from helix 10, also play a critical role in the correct folding of the transporter.
However, the last 12 amino acids of the cytoplasmic tail play no
essential role(s) in functional integrity of the G6PT. Our results, for
the first time, elucidate the structural requirements for the stability
and transport activity of the G6PT protein.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These two authors contributed equally to this work.
§
To whom correspondence should be addressed: Bldg. 10, Rm. 9S241,
National Institutes of Health, Bethesda, MD 20892-1830. Tel.: 301-496-1094; Fax: 301-402-6035; E-mail: chou@helix.nih.gov.
This article has been cited by other articles:
![]() |
S.-Y. Chen, C.-J. Pan, K. Nandigama, B. C. Mansfield, S. V. Ambudkar, and J. Y. Chou The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic FASEB J, July 1, 2008; 22(7): 2206 - 2213. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Chen, C.-J. Pan, J.-J. Shieh, and J. Y. Chou Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib Hum. Mol. Genet., December 1, 2002; 11(25): 3199 - 3207. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gerin, G. Noel, and E. Van Schaftingen Novel Arguments in Favor of the Substrate-Transport Model of Glucose-6-Phosphatase Diabetes, July 1, 2001; 50(7): 1531 - 1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hiraiwa, C.-J. Pan, B. Lin, T. E. Akiyama, F. J. Gonzalez, and J. Y. Chou A Molecular Link between the Common Phenotypes of Type 1 Glycogen Storage Disease and HNF1alpha -null Mice J. Biol. Chem., March 9, 2001; 276(11): 7963 - 7967. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |